VEGFR-TKIs alone or in combination with immune checkpoint inhibitors in clinical practice for the treatment of HCC
VEGFR-TKIs alone or in combination with immune checkpoint inhibitors in clinical practice for the treatment of HCC
Prof. Dr. Peter R. Galle, Dr. Amit Singal
In this HCC CONNECT podcast Prof. P. Galle and Prof. A. Singal discuss and debate different aspects for the use of VEGFR-TKIs alone or in combination with immune checkpoint inhibitors in clinical practice, Implementation of dosing-strategies and pre-habilitation of patients .
Prof. Dr. Peter R. Galle
Hepatologist
University of Mainz
Germany
Dr. Amit Singal
Gastroenterologist and Hepatologist
UT Southwestern Medical Center
United States (US)
| 
30 min
|
Nov 2021
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
In this medical education podcast episode, Prof. Peter Galle and Prof. Amit Singal discuss the use of VEGFR-TKIs in the treatment of advanced or unresectable HCC and explain the immunomodulation rationale to combine it with immune checkpoint inhibitor. Combination approach has been validated recently with the atezolizumab+bevacizumab combination being the new standard of care in 1L setting for advanced HCC patients. In the context of advanced HCC, both experts share their view about the dosing approach with VEGFR-TKI and provide insight to handle the dosing when combining with immune checkpoint inhibitors. Both experts reiterate that biomarkers are urgently needed in HCC and summarize the current stratification of patients used to predict the response with VEGFR-TKI monotherapy or in immunotherapy combination. Finally, they emphasize that pre-habilitation of HCC patients is key to make the HCC patient fit for the best available treatment option.
HCC CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Eisai Europe Limited.
Other programmes of interest
28 min
Other programmes developed by Prof. Dr. Peter R. Galle
Prof. Dr. Peter R. Galle
Hepatologist
University of Mainz
Germany
Other programmes developed by Dr. Amit Singal
Dr. Amit Singal
Gastroenterologist and Hepatologist
UT Southwestern Medical Center
United States (US)
